| Raskin P, Gylvin T, Weng W, et al.
Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes. [JOURNAL ARTICLE]
Diabetes Metab Res Rev 2009 Jun 29.
Abstract | Full Citation | | Hemkens LG, Grouven U, Bender R, et al.
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. [JOURNAL ARTICLE]
Diabetologia 2009 Jun 30.
Abstract | Full Citation | | Wiesli P, Krayenbühl P, Uthoff H, et al.
Omitting breakfast and lunch after injection of different long-acting insulin preparations at bedtime: a prospective study in patients with type 2 diabetes. [JOURNAL ARTICLE]
Diabetologia 2009 Jun 30.
Abstract | Full Citation | | Hossain MA, Belgi A, Lin F, et al.
Use of a Temporary "Solubilizing" Peptide Tag for the Fmoc Solid-Phase Synthesis of Human Insulin Glargine via Use of Regioselective Disulfide Bond Formation. [JOURNAL ARTICLE]
Bioconjug Chem 2009 Jun 24.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Marshall RD, Rand JS, Morton JM
Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins. [JOURNAL ARTICLE]
J Feline Med Surg 2009 Jun 16.
Abstract | Full Citation | Find Related Articles | | Hompesch M, Kollmeier A, Rave K, et al.
Glycemic exposure is affected favorably by inhaled human insulin (Exubera) as compared with subcutaneous insulin glargine (Lantus) in patients with type 2 diabetes. [Journal Article, Research Support, Non-U.S. Gov't]
Diabetes Technol Ther 2009 May; 11(5):307-13.
Abstract | Full Citation | | Rosenstock J, Fonseca V, McGill JB, et al.
Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. [JOURNAL ARTICLE]
Diabetologia 2009 Jun 13.
Abstract | Full Citation | | Garnock-Jones KP, Plosker GL
Insulin Glulisine: A Review of its Use in the Management of Diabetes Mellitus. [JOURNAL ARTICLE]
Drugs 2009 Jun 4; 69(8):1035-1057.
Abstract | Full Citation | | Heise T, Heinemann L, Hövelmann U, et al.
Biphasic insulin aspart 30/70 (BIAsp 30): pharmacokinetics (PK) and pharmacodynamics (PD) in comparison with once-daily biphasic human insulin and basal-bolus therapy. [JOURNAL ARTICLE]
Diabetes Care 2009 Jun 1.
Abstract | Full Citation | Find Related Articles | | Solostar pen for glargine and glulisine insulins: line extension. Less convenient than Innolet pen. [Journal Article]
Prescrire Int 2008 Aug; 17(96):138-9.
Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
